213Bi- DOTA(thienylalanyl(8)- methionyl(O2)(11))- substance P

used in targeted alpha-radionuclide therapy

Also Known As:

substance P, 213Bi-DOTA(thienylalanyl(8)-methionyl(O2)(11))-; 213Bi-DOTA(8-Thi-11-Met(O2))-substance P; 213Bi-DOTA(Thi(8),Met(O2)(11))-substance P; substance P, 213Bi-DOTA(Thi(8)-Met(O2)(11))-

Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - 213Bi-DOTA(thienylalanyl(8)-methionyl(O2)(11))- substance P
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Intercellular Signaling Peptides and Proteins: 29768
    - Kinins: 2029
      - Tachykinins: 869
        Substance P: 4846
        213Bi-DOTA(thienylalanyl(8)-methionyl(O2)(11))- substance P
  - Nerve Tissue Proteins: 2
    - Neuropeptides: 6772
      - Tachykinins: 869
        Substance P: 4846
        213Bi-DOTA(thienylalanyl(8)-methionyl(O2)(11))- substance P
- Peptides: 82426
Biological Factors: 2472
- Intercellular Signaling Peptides and Proteins: 29768
  - Kinins: 2029
    - Tachykinins: 869
      - Substance P: 4846
        213Bi-DOTA(thienylalanyl(8)-methionyl(O2)(11))- substance P
- Inflammation Mediators: 1113
  - Autacoids: 276
    - Kinins: 2029
      - Tachykinins: 869
        Substance P: 4846
        213Bi-DOTA(thienylalanyl(8)-methionyl(O2)(11))- substance P